Stephen Smith, MD
Ophthalmology · Fort Myers, FLNPI 1366438855
Payments from drug & device makers
Across 440 payments — averaging $1342.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Glaukos Corporation$236K
- AbbVie$144K
- Ocular Therapeutix, Inc.$102K
- Novartis$38K
- Bausch Health US, LLC$28K
- Sun Pharmaceutical Industries Inc.$24K
- plus $20K from 17 others
Across 28 payments — averaging $1734.47 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$42K
- Glaukos Corporation$6K
- Ocular Therapeutix, Inc.$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Glaukos Corporation | 142 | $235,604 |
| AbbVie(2 entities) | 124 | $144,304 |
| Ocular Therapeutix, Inc. | 11 | $101,608 |
| Novartis | 7 | $38,364 |
| Bausch Health US, LLC | 6 | $27,500 |
| Sun Pharmaceutical Industries Inc. | 21 | $23,578 |
| Ivantis, Inc | 4 | $17,320 |
| Kala Pharmaceuticals, Inc. | 55 | $653 |
| Alcon | 14 | $447 |
| Biotissue Holdings Inc. | 2 | $396 |
| Bausch & Lomb Americas Inc. | 22 | $374 |
| Mallinckrodt Hospital Products Inc. | 9 | $215 |
| Dompe US, Inc. | 4 | $108 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 5 | $89 |
| Amgen(2 entities) | 4 | $71 |
| Tarsus Pharmaceuticals, Inc. | 2 | $41 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $29 |
| Sight Sciences, Inc. | 2 | $28 |
| Oyster Point Pharma, Inc. | 1 | $23 |
| Rxsight Inc | 1 | $21 |
| Aerie Pharmaceuticals, Inc. | 1 | $20 |
| Harrow Eye, LLC | 1 | $16 |
| Iridex Corporation | 1 | $11 |
How this compares
$590,820 in reported general payments places this provider in the 95th percentile of 1,405 ophthalmology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Fort Myers
- David EichenbaumSt Petersburg$34.4M
- Robert RadenDelray Beach$7.8M
- Carl DanzigPompano Beach$5.3M
- Bruce SegalDelray Beach$4.7M
- Cathleen McCabeBradenton$4.6M
- Ivan SunerTampa$3.7M
- Sunir JoshiFt Lauderdale$3.7M
- Harold BrooksTallahassee$3.5M
- Matthew CunninghamOrlando$2.9M
- Benjamin ThomasJacksonville$2.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.